Skip to main content
Fig. 4 | BMC Cancer

Fig. 4

From: Enhanced tumor control activities of anti-mPD-L1 antibody and antigen-presenting cell-like natural killer cell in an allograft model

Fig. 4

Adoptively transferred NKDC showed synergetic effects with α-mPD-L1 antibody in E.7allograft mouse model

A total of 18 Female C57BL/6 mice were randomly grouped into five, followed by E.7 cell inoculation. Administration of NKDC and α-mPD-L1 followed the treatment schedule described in Fig. 3, respectively. The tumor volume of each mouse was measured every 2–3 days until sacrifice and showed in a line plot with mean ± SEM. *, p < 0.05

Back to article page